About YD Bio Limited Ordinary Shares

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Employees: 15
Price: $3.16
Previous close: $3.23
Market capitalization: $228.79M
Volume: 359,178
P/E ratio: -1.98
52-week low: $1.70
52-week high: $22.00

Additional performance and financial-statement views load in the interactive application.

Market information is provided for research and visualization and is not investment advice.